Evidence map›Paper›PMID 38718119›Full record

ArticleScience advances2024

Biomimetic piezoelectric nanomaterial-modified oral microrobots for targeted catalytic and immunotherapy of colorectal cancer.

Yueyue Fan, Jiamin Ye, Yong Kang, Gaoli Niu, Jiacheng Shi, Xue Yuan, Ruiyan Li, Jingwen Han, Xiaoyuan Ji

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Nanotechnology Meets Immunotherapy: Crosstalks Against Cancer.Immunity, inflammation and disease · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. MnOMaterials today. Bio · 2026
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yueyue FanAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.ORCID 0000-0002-7110-2886
Jiamin YeAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.ORCID 0009-0004-7234-7473
Yong KangAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.ORCID 0000-0002-0151-8683
Gaoli NiuAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.
Jiacheng ShiAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.ORCID 0000-0002-3572-2412
Xue YuanAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.
Ruiyan LiAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.
Jingwen HanAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.ORCID 0009-0008-3452-1273
Xiaoyuan JiAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin 300072, China.ORCID 0000-0002-6768-2304

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactic acid (LA) accumulation in the tumor microenvironment poses notable challenges to effective tumor immunotherapy. Here, an intelligent tumor treatment microrobot based on the unique physiological structure and metabolic characteristics of

Indexed as

Barium CompoundsBiomimetic MaterialsColorectal NeoplasmsImmunosuppression TherapyNanotubesRoboticsTitaniumTumor MicroenvironmentVeillonellaAdministration, OralCatalysisCell Line, TumorCell MembraneHumansLactic AcidOxidation-ReductionBarium Compoundsbarium titanate(IV)Lactic AcidTitanium

Identifiers

PMID38718119
PMCPMC11078194

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.